Associate Professor Liang Qiao

Associate Professor/Principal Research Fellow
Storr Liver Center, The Westmead Institute for Medical Research
University of Sydney at Westmead Clinical School at Westmead Hospital
176 Hawkesbury Road, Westmead, NSW 2145, Australia

Member of China Studies Centre

Telephone +612 6876 3534

Website Honours in Medical Sciences at Westmead

Map

Current research students

Project title Research student
Understanding novel genetic determinants of disease progression in NAFLD Ali BAYOUMI
Role of liver stem cells in the tumorigenic progression of liver cancer Romario NGUYEN

Selected grants

2014

  • Novel approaches to target cancer stem cells in liver cancer; Liddle C, Qiao L, Duan W, Hebbard L; Cancer Council New South Wales/Research Project Grants.
  • Metabolic drivers of liver cancer progression; Hebbard L, Qiao L; Cancer Council New South Wales/Research Project Grants.

2013

  • Characterization of ARL6IP5 in hepatitis C-related liver cancer; Qiao L, Douglas M, George J; National Health and Medical Research Council (NHMRC)/Project Grants.

2011

  • Regulation of Notch signalling by interlukine 6 in liver cancer cells; Qiao L; DVC Research/Bridging Support Grant.

2009

  • Identification and Characterisation of liver cancer stem cells and their regulation by notch signalling; Qiao L; Cancer Institute NSW/Future Research Leaders Grants.

Selected publications

Download citations: PDF RTF Endnote

Edited Books

  • Qiao, L., Li, Y., Yan, X., George, J. (2012). Molecular Aspects of Hepatocellular Carcinoma. Sharjah: Bentham Science Publishers.

Book Chapters

  • Lu, H., Wang, J., Wang, Y., Qiao, L., Zhou, Y. (2016). Embelin and its role in chronic diseases. In Subash Chandra Gupta, Sahdeo Prasad, Bharat B. Aggarwal (Eds.), Anti-inflammatory Nutraceuticals and Chronic Diseases, (pp. 397-418). Switzerland: Springer. [More Information]
  • Tian, A., Qiao, L., Yan, X. (2012). Aging and Hepatocellular Carcinoma: Possible Molecular Mechanisms. In Liang Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 80-85). Sharjah: Bentham Science Publishers. [More Information]
  • Liu, Q., Zhou, Y., Hu, Z., Qiao, L. (2012). An Overview on Molecular Therapy for Hepatocellular Carcinoma. In Liang Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 138-148). Sharjah: Bentham Science Publishers. [More Information]
  • Zhao, C., Liu, X., Shen, C., Wang, Y., Qiao, L. (2012). Treatment of Hepatocellular Carcinoma with Traditional Chinese Medicine: Possible Molecular Mechanisms. In Liang Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 167-173). Sharjah: Bentham Science Publishers. [More Information]

Journals

  • Zhang, J., Su, G., Tang, Z., Wang, L., Fu, W., Zhao, S., Ba, Y., Bai, B., Yue, P., Lin, Y., Qiao, L., et al (2018). Curcumol exerts anticancer effect in cholangiocarcinoma cells via down-regulating CDKL3. Frontiers in Physiology, 9(MAR). [More Information]
  • Pu, C., Huang, H., Wang, Z., Zou, W., Lv, Y., Zhou, Z., Zhang, Q., Qiao, L., Wu, F., Shao, S. (2018). Extracellular vesicle-associated mir-21 and mir-144 are markedly elevated in serum of patients with hepatocellular carcinoma. Frontiers in Physiology, 9(JUL), 1-8. [More Information]
  • Yuan, H., Chen, Z., Bai, S., Wei, H., Wang, Y., Ji, R., Guo, Q., Li, Q., Ye, Y., Wu, J., Qiao, L., et al (2018). Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer. Cancer Letters, 418, 84-96. [More Information]
  • Alzahrani, B., Iseli, T., Ramezani-Moghadam, M., Ho, V., Wankell, M., Sun, E., Qiao, L., George, J., Hebbard, L. (2018). The role of AdipoR1 and AdipoR2 in liver fibrosis. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1864 (3), 700-708. [More Information]
  • Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R., Esmaili, S., Ramezani-Moghadam, M., Devine, C., Read, S., Bhathal, P., Ahlenstiel, G., Qiao, L., George, J., Hebbard, L., et al (2017). Adiponectin confers protection from acute colitis and restricts a B cell immune response. Journal of Biological Chemistry, 292(16), 6569-6582. [More Information]
  • Peng, M., Zhang, Q., Cheng, Y., Fu, S., Yang, H., Gou, X., Zhang, J., Wang, L., Zhang, L., Xue, Z., Qiao, L., et al (2017). Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression. Oncotarget, 8(59), 99693-99706. [More Information]
  • Zhou, G., Latchoumanin, O., Bagdesar, M., Hebbard, L., Duan, W., Liddle, C., George, J., Qiao, L. (2017). Aptamer-based therapeutic approaches to target cancer stem cells. Theranostics, 7(16), 3948-3961. [More Information]
  • Huo, X., Han, S., Wu, G., Latchoumanin, O., Zhou, G., Qiao, L., George, J., Hebbard, L. (2017). Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: Implications for tumorigenesis, disease progression, and liver cancer stem cells. Molecular Cancer, 16(1), 1-10. [More Information]
  • Yan, S., Fan, J., Qiao, L. (2017). Hepatitis B virus (HBV) infection and hepatocellular carcinoma- New insights for an old topic. Current Cancer Drug Targets, 17(6), 505-511. [More Information]
  • Li, J., Zhou, Z., Zhang, X., Zheng, L., He, D., Ye, Y., Zhang, Q., Qi, C., He, X., Yu, C., Qiao, L., et al (2017). Inflammatory molecule, PSGL-1, deficiency activates macrophages to promote colorectal cancer growth through NFKB signaling. Molecular Cancer Research, 15(4), 467-477. [More Information]
  • Cai, Z., Xu, K., Li, Y., Lv, Y., Bao, J., Qiao, L. (2017). Long noncoding RNA in liver cancer stem cells. Discovery Medicine, 24(131), 87-93.
  • Bao, J., Qiao, L. (2017). New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy. Cancer Letters, 387, 1-2. [More Information]
  • Wu, G., Wilson, G., George, J., Liddle, C., Hebbard, L., Qiao, L. (2017). Overcoming treatment resistance in cancer: Current understanding and tactics. Cancer Letters, 387, 69-76. [More Information]
  • Han, S., Latchoumanin, O., Wu, G., Zhou, G., Hebbard, L., George, J., Qiao, L. (2017). Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumors. Cancer Letters, 390, 188-200. [More Information]
  • Kong, L., Lu, Y., Zhang, S., Nan, Y., Qiao, L. (2017). Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease. Discovery Medicine, 24(131), 95-106.
  • Fu, N., Yao, H., Nan, Y., Qiao, L. (2017). Role of oxidative stress in Hepatitis C Virus induced hepatocellular carcinoma. Current Cancer Drug Targets, 17(6), 498-504. [More Information]
  • Huang, B., Yang, H., Cheng, X., Wang, D., Fu, S., Shen, W., Zhang, Q., Zhang, L., Xue, Z., Qiao, L., et al (2017). TRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer. Cancer Research, 77(12), 3194-3206. [More Information]
  • Liu, X., Yang, Z., Latchoumanin, O., Qiao, L. (2016). Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer. Therapeutic Advances in Gastroenterology, 9(6), 853-860. [More Information]
  • Zhou, G., Wilson, G., Hebbard, L., Duan, W., Liddle, C., George, J., Qiao, L. (2016). Aptamers: A promising chemical antibody for cancer therapy. Oncotarget, 7(12), 13446-13463. [More Information]
  • Charrez, B., Qiao, L., Hebbard, L. (2016). Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. World Journal of Gastroenterology, 22(8), 2494-2502. [More Information]
  • Meng, P., Zhao, S., Niu, X., Fu, N., Su, S., Wang, R., Zhang, Y., Qiao, L., Nan, Y. (2016). Involvement of the interleukin-23/interleukin-17 axis in chronic hepatitis C virus infection and its treatment responses. International Journal of Molecular Sciences, 17(7), 1-15. [More Information]
  • Wu, T., Dai, Y., Wang, W., Teng, G., Jiao, H., Shuai, X., Zhang, R., Zhao, P., Qiao, L. (2016). Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer. Oncotarget, 7(15), 19548-19558. [More Information]
  • Huang, B., Cheng, X., Wang, H., Huang, W., Ga Hu, Z., Wang, D., Zhang, K., Zhang, H., Xue, Z., Qiao, L., et al (2016). Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. Journal of Translational Medicine, 14(1), 1-12. [More Information]
  • Liu, J., Pu, C., Lang, L., Qiao, L., Abdullahi, M., Jiang, C. (2016). Molecular pathogenesis of hereditary hemochromatosis. Histology and histopathology, 31(8), 833-840. [More Information]
  • Wang, H., Zhang, H., Zhang, Y., Wang, D., Cheng, X., Yang, F., Zhang, Q., Xue, Z., Li, Y., Qiao, L., et al (2016). Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget, 7(50), 82864-82875. [More Information]
  • Li, Y., Qiao, L. (2016). Role of cancer stem cells in common gastrointestinal cancers: From pathogenesis to therapeutic targets. Current Stem Cell Research & Therapy, 11(5), 426-426. [More Information]
  • Fu, N., Niu, X., Wang, Y., Du, H., Wang, B., Du, J., Li, Y., Wang, R., Zhang, Y., Qiao, L., et al (2016). Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis. Discovery Medicine, 22(119), 29-42.
  • Meng, W., Li, Y., Bai, B., Bai, Z., Yue, P., Li, X., Qiao, L. (2016). The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma. Discovery Medicine, 21(118), 489-494.
  • Chang, J., Lan, T., Li, C., Ji, X., Zheng, L., Gou, H., Ou, Y., Wu, T., Qi, C., Qiao, L., et al (2015). Activation of Slit2-Robo1 signaling promotes liver fibrosis. Journal of Hepatology, 63(6), 1413-1420. [More Information]
  • Ramezani-Moghadam, M., Wang, J., Ho, V., Iseli, T., Alzahrani, B., Xu, A., van der Poorten, D., Qiao, L., George, J., Hebbard, L. (2015). Adiponectin Reduces Hepatic Stellate Cell Migration by Promoting Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Secretion. Journal of Biological Chemistry, 290(9), 5533-5542. [More Information]
  • Xiang, D., Shigdar, S., Qiao, G., Zhou, S., Li, Y., Wei, M., Qiao, L., Al Shamaileh, H., Zhu, Y., Zheng, C., et al (2015). Aptamer-mediated cancer gene therapy. Current Gene Therapy: the international journal for in-depth reviews on gene therapy, 15(2), 109-119. [More Information]
  • Wang, Z., Zhou, W., Zhang, H., Qiao, L. (2015). Combination of Anti-Angiogenesis Agents and Transarterial Embolization: Is it a Promising Approach for the Treatment of Liver Cancer? Discovery Medicine, 20(108), 51-55.
  • Wilson, G., Hebbard, L., Duan, W., Qiao, L., George, J. (2015). Editorial: Gene therapy for gastrointestinal and liver cancers: past experience, current status and future perspectives. Current Gene Therapy, 15(2), 93-96. [More Information]
  • Wilson, G., Hebbard, L., Duan, W., George, J., Qiao, L. (2015). Editorial: Induced Pluripotent Stem Cells (iPSCs) in the Gastroenterology and Hepatology: from Basic Research to Clinical Applications. Current Stem Cell Research & Therapy, 10(3), 190-192.
  • Liu, X., Yang, Z., Chen, Z., Chen, R., Zhao, D., Zhou, Y., Qiao, L. (2015). Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells. Oncology Reports, 33(1), 157-162. [More Information]
  • Cheng, L., Zhang, Y., Nan, Y., Qiao, L. (2015). Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection. Current Stem Cell Research & Therapy, 10(3), 216-219. [More Information]
  • Wu, G., Wilson, G., George, J., Qiao, L. (2015). Modulation of Notch Signaling as a Therapeutic Approach for Liver Cancer. Current Gene Therapy, 15(2), 171-181. [More Information]
  • Wu, G., Wilson, G., Zhou, G., Hebbard, L., George, J., Qiao, L. (2015). Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma. Discovery Medicine, 20(110), 219-229.
  • Sun, C., Wilson, G., Fan, J., Qiao, L. (2015). Potential Applications of Induced Pluripotent Stem Cells (iPSCs) in Hepatology Research. Current Stem Cell Research & Therapy, 10(3), 208-215. [More Information]
  • Liu, S., Zhang, D., Chen, Y., Wang, B., Qiao, L. (2015). Potential Applications of Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Gastrointestinal Disorders. Current Stem Cell Research & Therapy, 10(3), 220-227. [More Information]
  • Sun, C., Fan, J., Qiao, L. (2015). Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 16(3), 5161-5179. [More Information]
  • Gao, J., Qiao, L., Wang, B. (2015). Primary Biliary Cirrhosis Is a Generalized Autoimmune Epithelitis. International Journal of Molecular Sciences, 16(3), 6432-6446. [More Information]
  • Zhang, L., Li, Y., Qiao, L., Zhao, Y., Wei, Y., Li, Y. (2015). Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells. International Journal of Oncology, 47(2), 632-640. [More Information]
  • Meng, W., Bai, B., Sheng, L., Li, Y., Yue, P., Li, X., Qiao, L. (2015). Role of helicobacter pylori in gastric cancer: Advances and controversies. Discovery Medicine, 20(111), 285-293.
  • Zhang, L., Song, X., Mohri, Y., Qiao, L. (2015). Role of Inflammation and Tumor Microenvironment in the Development of Gastrointestinal Cancers: What Induced Pluripotent Stem Cells Can Do? Current Stem Cell Research & Therapy, 10(3), 245-250. [More Information]
  • Zhang, Q., Zhou, D., Lei, Y., Zheng, L., Chen, S., Gou, H., Gu, Q., He, X., Lan, T., Qi, C., Qiao, L., et al (2015). Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway. Oncotarget, 6(5), 3123-3135. [More Information]
  • Zhou, G., Wilson, G., George, J., Qiao, L. (2015). Targeting cancer stem cells as a therapeutic approach in liver cancer. Current Gene Therapy, 15(2), 161-170. [More Information]
  • Charrez, B., Qiao, L., Hebbard, L. (2015). The role of fructose in metabolism and cancer. Hormone Molecular Biology and Clinical Investigation, 22(2), 79-89. [More Information]
  • Wu, F., Wang, J., Pu, C., Qiao, L., Jiang, C. (2015). Wilson's Disease: A Comprehensive Review of the Molecular Mechanisms. International Journal of Molecular Sciences, 16(3), 6419-6431. [More Information]
  • Chen, X., Liu, H., Li, M., Qiao, L. (2014). Advances in non-surgical management of primary liver cancer. World Journal of Gastroenterology, 20(44), 16630-16638. [More Information]
  • Qiao, L. (2014). Cancer Letters special issue inflammation andgastrointestinal and liver cancers featuring the guest editor. Cancer Letters, 345(2), 149-149. [More Information]
  • O'Connor, M., Xiang, D., Shigdar, S., Macdonald, J., Li, Y., Wang, T., Pu, C., Qiao, L., Duan, W. (2014). Cancer stem cells: A contentious hypothesis now moving forward. Cancer Letters, 344(2), 180-187. [More Information]
  • Zang, S., Liu, T., Shi, J., Qiao, L. (2014). Curcumin: a promising agent targeting cancer stem cells. Anti-Cancer Agents in Medicinal Chemistry, 14(6), 787-792. [More Information]
  • Peng, M., Huang, B., Zhang, Q., Fu, S., Wang, D., Cheng, X., Wu, X., Xue, Z., Zhang, L., Zhang, D., Qiao, L., et al (2014). Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells. Cancer Letters, 354(2), 407-416. [More Information]
  • Dai, Y., Jiao, H., Teng, G., Wang, W., Zhang, R., Wang, Y., Hebbard, L., George, J., Qiao, L. (2014). Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 Signaling. Molecular Cancer Therapeutics, 13(5), 1206-1216. [More Information]
  • Cao, H., Zhu, K., Fan, J., Qiao, L. (2014). Garlic-Derived Allyl Sulfides in Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry, 14(6), 793-799. [More Information]
  • Wang, F., Meng, W., Wang, B., Qiao, L. (2014). Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Letters, 345(2), 196-202. [More Information]
  • Xu, C., Zhou, W., Wang, Y., Qiao, L. (2014). Hepatitis B virus-induced hepatocellular carcinoma. Cancer Letters, 345(2), 216-222. [More Information]
  • Duan, X., Qin, P., Yan, S., Ding, W., Fan, J., Qiao, L. (2014). High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. BMC Gastroenterology, 14(1), 1-10. [More Information]
  • Lin, J., Shigdar, S., Fang, D., Xiang, D., Wei, M., Danks, A., Kong, L., Li, L., Qiao, L., Duan, W. (2014). Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model. PloS One, 9(7), 1-13. [More Information]
  • Duan, X., Zhang, L., Fan, J., Qiao, L. (2014). NAFLD leads to liver cancer: Do we have sufficient evidence? Cancer Letters, 345(2), 230-234. [More Information]
  • Zhou, W., Zhang, Q., Qiao, L. (2014). Pathogenesis of liver cirrhosis. World Journal of Gastroenterology, 20(23), 7312-7324. [More Information]
  • Qiao, L., Li, X. (2014). Role of chronic inflammation in cancers of the gastrointestinal system and the liver: where we are now. Cancer Letters, 1168, 207-225. [More Information]
  • Dai, Y., Wilson, G., Huang, B., Peng, M., Teng, G., Zhang, D., Zhang, R., Ebert, M., Chen, J., Wong, B., George, J., Qiao, L., et al (2014). Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Cell Death and Disease, 5, 1-9. [More Information]
  • Tian, A., Wilson, G., Lie, S., Wu, G., Hu, Z., Hebbard, L., Duan, W., George, J., Qiao, L. (2014). Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells. Cancer Letters, 351(2), 232-241. [More Information]
  • Peng, M., Xu, S., Zhang, Y., Zhang, L., Huang, B., Fu, S., Xue, Z., Da, Y., Dai, Y., Qiao, L., et al (2014). Thermosensitive injectable hydrogel enhances the antitumor effect of embelin in mouse hepatocellular carcinoma. Journal of Pharmaceutical Sciences, 103(3), 965-973. [More Information]
  • Shigdar, S., Macdonald, J., O'Connor, M., Wang, T., Xiang, D., Al.Shamaileh, H., Qiao, L., Wei, M., Zhou, S., Zhu, Y., et al (2013). Aptamers as theranostic agents: Modifications, serum stability and functionalisation. Sensors, 13(10), 13624-13637. [More Information]
  • Chen, Z., Liu, M., Liu, X., Huang, S., Li, L., Song, B., Li, H., Ren, Q., Zenan, H., Zhou, Y., Qiao, L. (2013). COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer. International Journal of Molecular Medicine, 32(1), 93-100. [More Information]
  • Wilson, G., Hu, Z., Duan, W., Tian, A., Wang, X., McCleod, D., Lam, V., George, J., Qiao, L. (2013). Efficacy of Using Cancer Stem Cell Markers in Isolating and Characterising Liver Cancer Stem Cells. Stem Cells and Development, 22(19), 2655-2664. [More Information]
  • Wang, Y., Li, Y., Li, X., Liu, T., Liu, X., Zhang, J., Guo, J., Guo, L., Qiao, L. (2013). Hypermethylation of TGF-beta1 gene promoter in gastric cancer. World Journal of Gastroenterology, 19(33), 5557-5564. [More Information]
  • Liu, X., Chen, Z., Li, H., Hu, Z., Liu, M., Tian, A., Zhao, D., Wu, J., Zhou, Y., Qiao, L. (2013). Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells. World Journal of Gastroenterology, 19(37), 6265-6271. [More Information]
  • Hu, Z., Liu, X., Tang, Z., Zhou, Y., Qiao, L. (2013). Possible regulatory role of Snail in NF-κB-mediated changes in E-cadherin in gastric cancer. Oncology Reports, 29(3), 993-1000. [More Information]
  • Pu, C., Wang, B., Qiao, L., Pu, C. (2013). Recent progress in research of biomarkers of acute kidney injury in liver cirrhosis. Zhonghua Ganzangbing Zazhi (Chinese Journal of Hepatology), 21(10), 796-798.
  • Shigdar, S., Qiao, L., Zhou, S., Xiang, D., Wang, T., Li, Y., Lim, L., Kong, L., Li, L., Duan, W. (2013). RNA aptamers targeting cancer stem cell marker CD133. Cancer Letters, 330(1), 84-95. [More Information]
  • Wilson, G., Tian, A., Hebbard, L., Duan, W., George, J., Li, X., Qiao, L. (2013). Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro. Cancer Letters, 341(2), 224-230. [More Information]
  • Vongsuvanh, R., George, J., Qiao, L., van der Poorten, D. (2013). Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Letters, 330(1), 1-10. [More Information]
  • Wang, F., Wang, B., Qiao, L. (2012). Association between obesity and gallbladder cancer. Frontiers in Bioscience, 17, 2550-2558. [More Information]
  • Duan, X., Qiao, L., Fan, J. (2012). Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International, 11(1), 18-27. [More Information]
  • Guo, L., Li, Y., Qiao, L., Liu, T., Du, Y., Zhang, J., He, W., Zhao, Y., He, D. (2012). Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45. World Journal of Gastroenterology, 18(48), 7262-7270. [More Information]
  • Li, Q., Zhang, J., Zhou, Y., Qiao, L. (2012). Obesity and gastric cancer. Frontiers in Bioscience, 17(7), 2383-2390. [More Information]
  • Shen, C., Zhao, C., Zhang, R., Qiao, L. (2012). Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity. Frontiers in Bioscience, 17(6), 2356-2370. [More Information]
  • Li, Z., Chim, J., Yang, M., Ye, J., Wong, B., Qiao, L. (2012). Role of PCDH10 and its hypermethylation in human gastric cancer. Biochimica et Biophysica Acta, 1823 (2), 298-305. [More Information]
  • Jiang, X., Huang, K., Yang, M., Qiao, L., Wang, Q., Ye, J., Zhou, H., Yi, Z., Wu, F., Wang, Z., et al (2012). Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-kB pathways. Cancer Letters, 326(2), 135-142. [More Information]
  • Li, Z., Chen, J., Chan, K., Qiao, L., Wong, B. (2011). A possible role of cIAP2 in Helicobacter pylori-associated gastric cancer. Cancer Letters, 313(2), 192-200. [More Information]
  • Liu, S., Wah Chan, K., Tong, J., Wang, Y., Wang, B., Qiao, L. (2011). PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literature. QJM: Quarterly Journal of Medicine, 104(6), 477-483. [More Information]
  • Wu, J., Lu, H., Ling, X., Wang, C., Rui, J., Wang, A., Qiao, L. (2011). {2-[(3-Carboxy-1-oxopropyl) amino]-2-deoxy-D-Glucose} suppresses proliferation and induces apoptosis in the human esophageal cancer cell line. Medical Oncology: a leading journal in clinical oncology, 28(4), 986-990. [More Information]
  • Zhou, Y., Li, G., Wu, J., Zhang, Z., Wu, Z., Fan, P., Hao, T., Zhang, X., Li, M., Zhang, F., Qiao, L., et al (2010). Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer. Tumor Biology, 31(6), 549-558. [More Information]
  • Ye, J., Chan, G., Qiao, L., Lian, Q., Meng, F., Luo, X., Khachigian, L., Ma, M., Deng, R., Chen, J., et al (2010). Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway. Haematologica, 95(10), 1745-1753. [More Information]
  • Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Zhang, R., Ma, J., Zou, B., Lam, C., Wang, J., et al (2009). Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer. Molecular Cancer Therapeutics, 8(9), 2762-2770. [More Information]
  • Liu, S., Chan, K., Wang, B., Qiao, L. (2009). Fibrolamellar Hepatocellular Carcinoma. American Journal of Gastroenterology, 104(10), 2617-2624. [More Information]
  • Wang, J., Gu, Q., Li, M., Zhang, W., Yang, M., Zou, B., Chan, S., Qiao, L., Jiang, B., Tu, S., et al (2009). Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer. Carcinogenesis, 30(9), 1507-1516. [More Information]
  • Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Ma, J., Zou, B., Gu, Q., Wang, J., Lan, H., et al (2009). Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Research, 69(11), 4776-4783. [More Information]
  • Qiao, L., Wong, B. (2009). Role of Notch signaling in colorectal cancer. Carcinogenesis, 30(12), 1979-1986. [More Information]
  • Wu, J., Ren, D., Zhou, Y., Zhang, Z., Zhang, Z., Yan, X., Wang, Q., Wang, Z., Wang, H., Zhang, J., et al (2008). A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Letters, 269(1), 18-25. [More Information]
  • Ma, J., Yang, X., Qiao, L., Liang, L., Chen, M. (2008). CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy. Journal of Digestive Diseases, 9(2), 79-83. [More Information]
  • Qiao, L., Zhang, H., Yu, J., Francisco, R., Dent, P., Ebert, M., Röcken, C., Farrell, G. (2006). Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. Human Gene Therapy, 17(3), 280-290. [More Information]
  • Hsu, M., Qiao, L., Ho, V., Zhang, B., Zhang, H., Teoh, N., Dent, P., Farrell, G. (2006). Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats. Journal of Hepatology, 44(2), 375-382. [More Information]
  • Yu, J., Qiao, L., Zimmermann, L., Ebert, M., Zhang, H., Lin, W., Röcken, C., Malfertheiner, P., Farrell, G. (2006). Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology, 43(1), 134-143. [More Information]
  • Wu, J., Qi, D., Wei, K., Li, J., Chen, X., Wang, A., liu, W., Xue, Q., Qiao, L. (2005). 2-[(3-carboxy-1-oxoprogy1) amino]-2-deoxy-D-glucose induces apoptosis in Hep G2 cells. Experimental Oncology, 27(1), 52-55.
  • Wu, J., Kou, W., Gao, M., Zubal, G., Wang, A., Xue, Q., Qiao, L. (2005). Effects of {2-(3-carboxy-1-oxoprogy 1)amino-2-deoxy-D-glucose} on human hepatocellular carcinoma cell line. Acta Pharmacologica Sinica, 26(5), 635-640.
  • Qiao, L., Yu, J., Dent, P., Farrell, G. (2005). NF-kappaB Protects Rat ARL-6 Hepatocellular Carcinoma Cells Against Hydrogen Peroxide-Induced Apoptosis. Cancer Biology and Therapy, 4(11), 1195-1202. [More Information]
  • Liu, Q., Ma, K., He, Z., Dong, J., Hua, X., Huang, X., Qiao, L. (2005). Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: A pilot study. Journal of Gastrointestinal Surgery, 9(5), 648-657. [More Information]

Conferences

  • Farrell, G., Hou, J., Zhang, H., Francisco, R., Nan, Y., Osvath, S., Qiao, L., Dela Pena, A., Sedger, L. (2005). Apoptosis occurs early and involves trail receptors, while hepatocellular proliferation is delayed but vigorous in a murine dietary model of steatohepatitis. 56th Annual Meeting of the American Association for the Study of Liver Diseases, United States: John Wiley & Sons.

2018

  • Zhang, J., Su, G., Tang, Z., Wang, L., Fu, W., Zhao, S., Ba, Y., Bai, B., Yue, P., Lin, Y., Qiao, L., et al (2018). Curcumol exerts anticancer effect in cholangiocarcinoma cells via down-regulating CDKL3. Frontiers in Physiology, 9(MAR). [More Information]
  • Pu, C., Huang, H., Wang, Z., Zou, W., Lv, Y., Zhou, Z., Zhang, Q., Qiao, L., Wu, F., Shao, S. (2018). Extracellular vesicle-associated mir-21 and mir-144 are markedly elevated in serum of patients with hepatocellular carcinoma. Frontiers in Physiology, 9(JUL), 1-8. [More Information]
  • Yuan, H., Chen, Z., Bai, S., Wei, H., Wang, Y., Ji, R., Guo, Q., Li, Q., Ye, Y., Wu, J., Qiao, L., et al (2018). Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer. Cancer Letters, 418, 84-96. [More Information]
  • Alzahrani, B., Iseli, T., Ramezani-Moghadam, M., Ho, V., Wankell, M., Sun, E., Qiao, L., George, J., Hebbard, L. (2018). The role of AdipoR1 and AdipoR2 in liver fibrosis. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1864 (3), 700-708. [More Information]

2017

  • Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R., Esmaili, S., Ramezani-Moghadam, M., Devine, C., Read, S., Bhathal, P., Ahlenstiel, G., Qiao, L., George, J., Hebbard, L., et al (2017). Adiponectin confers protection from acute colitis and restricts a B cell immune response. Journal of Biological Chemistry, 292(16), 6569-6582. [More Information]
  • Peng, M., Zhang, Q., Cheng, Y., Fu, S., Yang, H., Gou, X., Zhang, J., Wang, L., Zhang, L., Xue, Z., Qiao, L., et al (2017). Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression. Oncotarget, 8(59), 99693-99706. [More Information]
  • Zhou, G., Latchoumanin, O., Bagdesar, M., Hebbard, L., Duan, W., Liddle, C., George, J., Qiao, L. (2017). Aptamer-based therapeutic approaches to target cancer stem cells. Theranostics, 7(16), 3948-3961. [More Information]
  • Huo, X., Han, S., Wu, G., Latchoumanin, O., Zhou, G., Qiao, L., George, J., Hebbard, L. (2017). Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: Implications for tumorigenesis, disease progression, and liver cancer stem cells. Molecular Cancer, 16(1), 1-10. [More Information]
  • Yan, S., Fan, J., Qiao, L. (2017). Hepatitis B virus (HBV) infection and hepatocellular carcinoma- New insights for an old topic. Current Cancer Drug Targets, 17(6), 505-511. [More Information]
  • Li, J., Zhou, Z., Zhang, X., Zheng, L., He, D., Ye, Y., Zhang, Q., Qi, C., He, X., Yu, C., Qiao, L., et al (2017). Inflammatory molecule, PSGL-1, deficiency activates macrophages to promote colorectal cancer growth through NFKB signaling. Molecular Cancer Research, 15(4), 467-477. [More Information]
  • Cai, Z., Xu, K., Li, Y., Lv, Y., Bao, J., Qiao, L. (2017). Long noncoding RNA in liver cancer stem cells. Discovery Medicine, 24(131), 87-93.
  • Bao, J., Qiao, L. (2017). New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy. Cancer Letters, 387, 1-2. [More Information]
  • Wu, G., Wilson, G., George, J., Liddle, C., Hebbard, L., Qiao, L. (2017). Overcoming treatment resistance in cancer: Current understanding and tactics. Cancer Letters, 387, 69-76. [More Information]
  • Han, S., Latchoumanin, O., Wu, G., Zhou, G., Hebbard, L., George, J., Qiao, L. (2017). Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumors. Cancer Letters, 390, 188-200. [More Information]
  • Kong, L., Lu, Y., Zhang, S., Nan, Y., Qiao, L. (2017). Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease. Discovery Medicine, 24(131), 95-106.
  • Fu, N., Yao, H., Nan, Y., Qiao, L. (2017). Role of oxidative stress in Hepatitis C Virus induced hepatocellular carcinoma. Current Cancer Drug Targets, 17(6), 498-504. [More Information]
  • Huang, B., Yang, H., Cheng, X., Wang, D., Fu, S., Shen, W., Zhang, Q., Zhang, L., Xue, Z., Qiao, L., et al (2017). TRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer. Cancer Research, 77(12), 3194-3206. [More Information]

2016

  • Liu, X., Yang, Z., Latchoumanin, O., Qiao, L. (2016). Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer. Therapeutic Advances in Gastroenterology, 9(6), 853-860. [More Information]
  • Zhou, G., Wilson, G., Hebbard, L., Duan, W., Liddle, C., George, J., Qiao, L. (2016). Aptamers: A promising chemical antibody for cancer therapy. Oncotarget, 7(12), 13446-13463. [More Information]
  • Lu, H., Wang, J., Wang, Y., Qiao, L., Zhou, Y. (2016). Embelin and its role in chronic diseases. In Subash Chandra Gupta, Sahdeo Prasad, Bharat B. Aggarwal (Eds.), Anti-inflammatory Nutraceuticals and Chronic Diseases, (pp. 397-418). Switzerland: Springer. [More Information]
  • Charrez, B., Qiao, L., Hebbard, L. (2016). Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. World Journal of Gastroenterology, 22(8), 2494-2502. [More Information]
  • Meng, P., Zhao, S., Niu, X., Fu, N., Su, S., Wang, R., Zhang, Y., Qiao, L., Nan, Y. (2016). Involvement of the interleukin-23/interleukin-17 axis in chronic hepatitis C virus infection and its treatment responses. International Journal of Molecular Sciences, 17(7), 1-15. [More Information]
  • Wu, T., Dai, Y., Wang, W., Teng, G., Jiao, H., Shuai, X., Zhang, R., Zhao, P., Qiao, L. (2016). Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer. Oncotarget, 7(15), 19548-19558. [More Information]
  • Huang, B., Cheng, X., Wang, H., Huang, W., Ga Hu, Z., Wang, D., Zhang, K., Zhang, H., Xue, Z., Qiao, L., et al (2016). Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. Journal of Translational Medicine, 14(1), 1-12. [More Information]
  • Liu, J., Pu, C., Lang, L., Qiao, L., Abdullahi, M., Jiang, C. (2016). Molecular pathogenesis of hereditary hemochromatosis. Histology and histopathology, 31(8), 833-840. [More Information]
  • Wang, H., Zhang, H., Zhang, Y., Wang, D., Cheng, X., Yang, F., Zhang, Q., Xue, Z., Li, Y., Qiao, L., et al (2016). Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget, 7(50), 82864-82875. [More Information]
  • Li, Y., Qiao, L. (2016). Role of cancer stem cells in common gastrointestinal cancers: From pathogenesis to therapeutic targets. Current Stem Cell Research & Therapy, 11(5), 426-426. [More Information]
  • Fu, N., Niu, X., Wang, Y., Du, H., Wang, B., Du, J., Li, Y., Wang, R., Zhang, Y., Qiao, L., et al (2016). Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis. Discovery Medicine, 22(119), 29-42.
  • Meng, W., Li, Y., Bai, B., Bai, Z., Yue, P., Li, X., Qiao, L. (2016). The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma. Discovery Medicine, 21(118), 489-494.

2015

  • Chang, J., Lan, T., Li, C., Ji, X., Zheng, L., Gou, H., Ou, Y., Wu, T., Qi, C., Qiao, L., et al (2015). Activation of Slit2-Robo1 signaling promotes liver fibrosis. Journal of Hepatology, 63(6), 1413-1420. [More Information]
  • Ramezani-Moghadam, M., Wang, J., Ho, V., Iseli, T., Alzahrani, B., Xu, A., van der Poorten, D., Qiao, L., George, J., Hebbard, L. (2015). Adiponectin Reduces Hepatic Stellate Cell Migration by Promoting Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Secretion. Journal of Biological Chemistry, 290(9), 5533-5542. [More Information]
  • Xiang, D., Shigdar, S., Qiao, G., Zhou, S., Li, Y., Wei, M., Qiao, L., Al Shamaileh, H., Zhu, Y., Zheng, C., et al (2015). Aptamer-mediated cancer gene therapy. Current Gene Therapy: the international journal for in-depth reviews on gene therapy, 15(2), 109-119. [More Information]
  • Wang, Z., Zhou, W., Zhang, H., Qiao, L. (2015). Combination of Anti-Angiogenesis Agents and Transarterial Embolization: Is it a Promising Approach for the Treatment of Liver Cancer? Discovery Medicine, 20(108), 51-55.
  • Wilson, G., Hebbard, L., Duan, W., Qiao, L., George, J. (2015). Editorial: Gene therapy for gastrointestinal and liver cancers: past experience, current status and future perspectives. Current Gene Therapy, 15(2), 93-96. [More Information]
  • Wilson, G., Hebbard, L., Duan, W., George, J., Qiao, L. (2015). Editorial: Induced Pluripotent Stem Cells (iPSCs) in the Gastroenterology and Hepatology: from Basic Research to Clinical Applications. Current Stem Cell Research & Therapy, 10(3), 190-192.
  • Liu, X., Yang, Z., Chen, Z., Chen, R., Zhao, D., Zhou, Y., Qiao, L. (2015). Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells. Oncology Reports, 33(1), 157-162. [More Information]
  • Cheng, L., Zhang, Y., Nan, Y., Qiao, L. (2015). Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection. Current Stem Cell Research & Therapy, 10(3), 216-219. [More Information]
  • Wu, G., Wilson, G., George, J., Qiao, L. (2015). Modulation of Notch Signaling as a Therapeutic Approach for Liver Cancer. Current Gene Therapy, 15(2), 171-181. [More Information]
  • Wu, G., Wilson, G., Zhou, G., Hebbard, L., George, J., Qiao, L. (2015). Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma. Discovery Medicine, 20(110), 219-229.
  • Sun, C., Wilson, G., Fan, J., Qiao, L. (2015). Potential Applications of Induced Pluripotent Stem Cells (iPSCs) in Hepatology Research. Current Stem Cell Research & Therapy, 10(3), 208-215. [More Information]
  • Liu, S., Zhang, D., Chen, Y., Wang, B., Qiao, L. (2015). Potential Applications of Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Gastrointestinal Disorders. Current Stem Cell Research & Therapy, 10(3), 220-227. [More Information]
  • Sun, C., Fan, J., Qiao, L. (2015). Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 16(3), 5161-5179. [More Information]
  • Gao, J., Qiao, L., Wang, B. (2015). Primary Biliary Cirrhosis Is a Generalized Autoimmune Epithelitis. International Journal of Molecular Sciences, 16(3), 6432-6446. [More Information]
  • Zhang, L., Li, Y., Qiao, L., Zhao, Y., Wei, Y., Li, Y. (2015). Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells. International Journal of Oncology, 47(2), 632-640. [More Information]
  • Meng, W., Bai, B., Sheng, L., Li, Y., Yue, P., Li, X., Qiao, L. (2015). Role of helicobacter pylori in gastric cancer: Advances and controversies. Discovery Medicine, 20(111), 285-293.
  • Zhang, L., Song, X., Mohri, Y., Qiao, L. (2015). Role of Inflammation and Tumor Microenvironment in the Development of Gastrointestinal Cancers: What Induced Pluripotent Stem Cells Can Do? Current Stem Cell Research & Therapy, 10(3), 245-250. [More Information]
  • Zhang, Q., Zhou, D., Lei, Y., Zheng, L., Chen, S., Gou, H., Gu, Q., He, X., Lan, T., Qi, C., Qiao, L., et al (2015). Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway. Oncotarget, 6(5), 3123-3135. [More Information]
  • Zhou, G., Wilson, G., George, J., Qiao, L. (2015). Targeting cancer stem cells as a therapeutic approach in liver cancer. Current Gene Therapy, 15(2), 161-170. [More Information]
  • Charrez, B., Qiao, L., Hebbard, L. (2015). The role of fructose in metabolism and cancer. Hormone Molecular Biology and Clinical Investigation, 22(2), 79-89. [More Information]
  • Wu, F., Wang, J., Pu, C., Qiao, L., Jiang, C. (2015). Wilson's Disease: A Comprehensive Review of the Molecular Mechanisms. International Journal of Molecular Sciences, 16(3), 6419-6431. [More Information]

2014

  • Chen, X., Liu, H., Li, M., Qiao, L. (2014). Advances in non-surgical management of primary liver cancer. World Journal of Gastroenterology, 20(44), 16630-16638. [More Information]
  • Qiao, L. (2014). Cancer Letters special issue inflammation andgastrointestinal and liver cancers featuring the guest editor. Cancer Letters, 345(2), 149-149. [More Information]
  • O'Connor, M., Xiang, D., Shigdar, S., Macdonald, J., Li, Y., Wang, T., Pu, C., Qiao, L., Duan, W. (2014). Cancer stem cells: A contentious hypothesis now moving forward. Cancer Letters, 344(2), 180-187. [More Information]
  • Zang, S., Liu, T., Shi, J., Qiao, L. (2014). Curcumin: a promising agent targeting cancer stem cells. Anti-Cancer Agents in Medicinal Chemistry, 14(6), 787-792. [More Information]
  • Peng, M., Huang, B., Zhang, Q., Fu, S., Wang, D., Cheng, X., Wu, X., Xue, Z., Zhang, L., Zhang, D., Qiao, L., et al (2014). Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells. Cancer Letters, 354(2), 407-416. [More Information]
  • Dai, Y., Jiao, H., Teng, G., Wang, W., Zhang, R., Wang, Y., Hebbard, L., George, J., Qiao, L. (2014). Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 Signaling. Molecular Cancer Therapeutics, 13(5), 1206-1216. [More Information]
  • Cao, H., Zhu, K., Fan, J., Qiao, L. (2014). Garlic-Derived Allyl Sulfides in Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry, 14(6), 793-799. [More Information]
  • Wang, F., Meng, W., Wang, B., Qiao, L. (2014). Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Letters, 345(2), 196-202. [More Information]
  • Xu, C., Zhou, W., Wang, Y., Qiao, L. (2014). Hepatitis B virus-induced hepatocellular carcinoma. Cancer Letters, 345(2), 216-222. [More Information]
  • Duan, X., Qin, P., Yan, S., Ding, W., Fan, J., Qiao, L. (2014). High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. BMC Gastroenterology, 14(1), 1-10. [More Information]
  • Lin, J., Shigdar, S., Fang, D., Xiang, D., Wei, M., Danks, A., Kong, L., Li, L., Qiao, L., Duan, W. (2014). Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model. PloS One, 9(7), 1-13. [More Information]
  • Duan, X., Zhang, L., Fan, J., Qiao, L. (2014). NAFLD leads to liver cancer: Do we have sufficient evidence? Cancer Letters, 345(2), 230-234. [More Information]
  • Zhou, W., Zhang, Q., Qiao, L. (2014). Pathogenesis of liver cirrhosis. World Journal of Gastroenterology, 20(23), 7312-7324. [More Information]
  • Qiao, L., Li, X. (2014). Role of chronic inflammation in cancers of the gastrointestinal system and the liver: where we are now. Cancer Letters, 1168, 207-225. [More Information]
  • Dai, Y., Wilson, G., Huang, B., Peng, M., Teng, G., Zhang, D., Zhang, R., Ebert, M., Chen, J., Wong, B., George, J., Qiao, L., et al (2014). Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Cell Death and Disease, 5, 1-9. [More Information]
  • Tian, A., Wilson, G., Lie, S., Wu, G., Hu, Z., Hebbard, L., Duan, W., George, J., Qiao, L. (2014). Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells. Cancer Letters, 351(2), 232-241. [More Information]
  • Peng, M., Xu, S., Zhang, Y., Zhang, L., Huang, B., Fu, S., Xue, Z., Da, Y., Dai, Y., Qiao, L., et al (2014). Thermosensitive injectable hydrogel enhances the antitumor effect of embelin in mouse hepatocellular carcinoma. Journal of Pharmaceutical Sciences, 103(3), 965-973. [More Information]

2013

  • Shigdar, S., Macdonald, J., O'Connor, M., Wang, T., Xiang, D., Al.Shamaileh, H., Qiao, L., Wei, M., Zhou, S., Zhu, Y., et al (2013). Aptamers as theranostic agents: Modifications, serum stability and functionalisation. Sensors, 13(10), 13624-13637. [More Information]
  • Chen, Z., Liu, M., Liu, X., Huang, S., Li, L., Song, B., Li, H., Ren, Q., Zenan, H., Zhou, Y., Qiao, L. (2013). COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer. International Journal of Molecular Medicine, 32(1), 93-100. [More Information]
  • Wilson, G., Hu, Z., Duan, W., Tian, A., Wang, X., McCleod, D., Lam, V., George, J., Qiao, L. (2013). Efficacy of Using Cancer Stem Cell Markers in Isolating and Characterising Liver Cancer Stem Cells. Stem Cells and Development, 22(19), 2655-2664. [More Information]
  • Wang, Y., Li, Y., Li, X., Liu, T., Liu, X., Zhang, J., Guo, J., Guo, L., Qiao, L. (2013). Hypermethylation of TGF-beta1 gene promoter in gastric cancer. World Journal of Gastroenterology, 19(33), 5557-5564. [More Information]
  • Liu, X., Chen, Z., Li, H., Hu, Z., Liu, M., Tian, A., Zhao, D., Wu, J., Zhou, Y., Qiao, L. (2013). Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells. World Journal of Gastroenterology, 19(37), 6265-6271. [More Information]
  • Hu, Z., Liu, X., Tang, Z., Zhou, Y., Qiao, L. (2013). Possible regulatory role of Snail in NF-κB-mediated changes in E-cadherin in gastric cancer. Oncology Reports, 29(3), 993-1000. [More Information]
  • Pu, C., Wang, B., Qiao, L., Pu, C. (2013). Recent progress in research of biomarkers of acute kidney injury in liver cirrhosis. Zhonghua Ganzangbing Zazhi (Chinese Journal of Hepatology), 21(10), 796-798.
  • Shigdar, S., Qiao, L., Zhou, S., Xiang, D., Wang, T., Li, Y., Lim, L., Kong, L., Li, L., Duan, W. (2013). RNA aptamers targeting cancer stem cell marker CD133. Cancer Letters, 330(1), 84-95. [More Information]
  • Wilson, G., Tian, A., Hebbard, L., Duan, W., George, J., Li, X., Qiao, L. (2013). Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro. Cancer Letters, 341(2), 224-230. [More Information]
  • Vongsuvanh, R., George, J., Qiao, L., van der Poorten, D. (2013). Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Letters, 330(1), 1-10. [More Information]

2012

  • Tian, A., Qiao, L., Yan, X. (2012). Aging and Hepatocellular Carcinoma: Possible Molecular Mechanisms. In Liang Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 80-85). Sharjah: Bentham Science Publishers. [More Information]
  • Liu, Q., Zhou, Y., Hu, Z., Qiao, L. (2012). An Overview on Molecular Therapy for Hepatocellular Carcinoma. In Liang Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 138-148). Sharjah: Bentham Science Publishers. [More Information]
  • Wang, F., Wang, B., Qiao, L. (2012). Association between obesity and gallbladder cancer. Frontiers in Bioscience, 17, 2550-2558. [More Information]
  • Duan, X., Qiao, L., Fan, J. (2012). Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International, 11(1), 18-27. [More Information]
  • Qiao, L., Li, Y., Yan, X., George, J. (2012). Molecular Aspects of Hepatocellular Carcinoma. Sharjah: Bentham Science Publishers.
  • Guo, L., Li, Y., Qiao, L., Liu, T., Du, Y., Zhang, J., He, W., Zhao, Y., He, D. (2012). Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45. World Journal of Gastroenterology, 18(48), 7262-7270. [More Information]
  • Li, Q., Zhang, J., Zhou, Y., Qiao, L. (2012). Obesity and gastric cancer. Frontiers in Bioscience, 17(7), 2383-2390. [More Information]
  • Shen, C., Zhao, C., Zhang, R., Qiao, L. (2012). Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity. Frontiers in Bioscience, 17(6), 2356-2370. [More Information]
  • Li, Z., Chim, J., Yang, M., Ye, J., Wong, B., Qiao, L. (2012). Role of PCDH10 and its hypermethylation in human gastric cancer. Biochimica et Biophysica Acta, 1823 (2), 298-305. [More Information]
  • Jiang, X., Huang, K., Yang, M., Qiao, L., Wang, Q., Ye, J., Zhou, H., Yi, Z., Wu, F., Wang, Z., et al (2012). Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-kB pathways. Cancer Letters, 326(2), 135-142. [More Information]
  • Zhao, C., Liu, X., Shen, C., Wang, Y., Qiao, L. (2012). Treatment of Hepatocellular Carcinoma with Traditional Chinese Medicine: Possible Molecular Mechanisms. In Liang Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 167-173). Sharjah: Bentham Science Publishers. [More Information]

2011

  • Li, Z., Chen, J., Chan, K., Qiao, L., Wong, B. (2011). A possible role of cIAP2 in Helicobacter pylori-associated gastric cancer. Cancer Letters, 313(2), 192-200. [More Information]
  • Liu, S., Wah Chan, K., Tong, J., Wang, Y., Wang, B., Qiao, L. (2011). PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literature. QJM: Quarterly Journal of Medicine, 104(6), 477-483. [More Information]
  • Wu, J., Lu, H., Ling, X., Wang, C., Rui, J., Wang, A., Qiao, L. (2011). {2-[(3-Carboxy-1-oxopropyl) amino]-2-deoxy-D-Glucose} suppresses proliferation and induces apoptosis in the human esophageal cancer cell line. Medical Oncology: a leading journal in clinical oncology, 28(4), 986-990. [More Information]

2010

  • Zhou, Y., Li, G., Wu, J., Zhang, Z., Wu, Z., Fan, P., Hao, T., Zhang, X., Li, M., Zhang, F., Qiao, L., et al (2010). Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer. Tumor Biology, 31(6), 549-558. [More Information]
  • Ye, J., Chan, G., Qiao, L., Lian, Q., Meng, F., Luo, X., Khachigian, L., Ma, M., Deng, R., Chen, J., et al (2010). Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway. Haematologica, 95(10), 1745-1753. [More Information]

2009

  • Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Zhang, R., Ma, J., Zou, B., Lam, C., Wang, J., et al (2009). Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer. Molecular Cancer Therapeutics, 8(9), 2762-2770. [More Information]
  • Liu, S., Chan, K., Wang, B., Qiao, L. (2009). Fibrolamellar Hepatocellular Carcinoma. American Journal of Gastroenterology, 104(10), 2617-2624. [More Information]
  • Wang, J., Gu, Q., Li, M., Zhang, W., Yang, M., Zou, B., Chan, S., Qiao, L., Jiang, B., Tu, S., et al (2009). Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer. Carcinogenesis, 30(9), 1507-1516. [More Information]
  • Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Ma, J., Zou, B., Gu, Q., Wang, J., Lan, H., et al (2009). Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Research, 69(11), 4776-4783. [More Information]
  • Qiao, L., Wong, B. (2009). Role of Notch signaling in colorectal cancer. Carcinogenesis, 30(12), 1979-1986. [More Information]

2008

  • Wu, J., Ren, D., Zhou, Y., Zhang, Z., Zhang, Z., Yan, X., Wang, Q., Wang, Z., Wang, H., Zhang, J., et al (2008). A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Letters, 269(1), 18-25. [More Information]
  • Ma, J., Yang, X., Qiao, L., Liang, L., Chen, M. (2008). CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy. Journal of Digestive Diseases, 9(2), 79-83. [More Information]

2006

  • Qiao, L., Zhang, H., Yu, J., Francisco, R., Dent, P., Ebert, M., Röcken, C., Farrell, G. (2006). Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. Human Gene Therapy, 17(3), 280-290. [More Information]
  • Hsu, M., Qiao, L., Ho, V., Zhang, B., Zhang, H., Teoh, N., Dent, P., Farrell, G. (2006). Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats. Journal of Hepatology, 44(2), 375-382. [More Information]
  • Yu, J., Qiao, L., Zimmermann, L., Ebert, M., Zhang, H., Lin, W., Röcken, C., Malfertheiner, P., Farrell, G. (2006). Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology, 43(1), 134-143. [More Information]

2005

  • Wu, J., Qi, D., Wei, K., Li, J., Chen, X., Wang, A., liu, W., Xue, Q., Qiao, L. (2005). 2-[(3-carboxy-1-oxoprogy1) amino]-2-deoxy-D-glucose induces apoptosis in Hep G2 cells. Experimental Oncology, 27(1), 52-55.
  • Farrell, G., Hou, J., Zhang, H., Francisco, R., Nan, Y., Osvath, S., Qiao, L., Dela Pena, A., Sedger, L. (2005). Apoptosis occurs early and involves trail receptors, while hepatocellular proliferation is delayed but vigorous in a murine dietary model of steatohepatitis. 56th Annual Meeting of the American Association for the Study of Liver Diseases, United States: John Wiley & Sons.
  • Wu, J., Kou, W., Gao, M., Zubal, G., Wang, A., Xue, Q., Qiao, L. (2005). Effects of {2-(3-carboxy-1-oxoprogy 1)amino-2-deoxy-D-glucose} on human hepatocellular carcinoma cell line. Acta Pharmacologica Sinica, 26(5), 635-640.
  • Qiao, L., Yu, J., Dent, P., Farrell, G. (2005). NF-kappaB Protects Rat ARL-6 Hepatocellular Carcinoma Cells Against Hydrogen Peroxide-Induced Apoptosis. Cancer Biology and Therapy, 4(11), 1195-1202. [More Information]
  • Liu, Q., Ma, K., He, Z., Dong, J., Hua, X., Huang, X., Qiao, L. (2005). Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: A pilot study. Journal of Gastrointestinal Surgery, 9(5), 648-657. [More Information]

To update your profile click here. For support on your academic profile contact .